Nanoparticle delivery of a tetravalent E protein subunit vaccine induces balanced, type-specific neutralizing antibodies to each dengue virus serotype.
Dengue virus (DENV) is the causative agent of dengue fever and dengue hemorrhagic shock syndrome. Dengue vaccine development is challenging because of the need to induce protection against four antigenically distinct DENV serotypes. Recent studies indicate that tetravalent DENV vaccines must induce...
Main Authors: | Stefan W Metz, Ashlie Thomas, Alex Brackbill, Yi Xianwen, Michele Stone, Katie Horvath, Michael J Miley, Chris Luft, Joseph M DeSimone, Shaomin Tian, Aravinda M de Silva |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2018-09-01
|
Series: | PLoS Neglected Tropical Diseases |
Online Access: | http://europepmc.org/articles/PMC6171938?pdf=render |
Similar Items
-
Precisely Molded Nanoparticle Displaying DENV-E Proteins Induces Robust Serotype-Specific Neutralizing Antibody Responses.
by: Stefan W Metz, et al.
Published: (2016-10-01) -
Defining levels of dengue virus serotype-specific neutralizing antibodies induced by a live attenuated tetravalent dengue vaccine (TAK-003).
by: Laura J White, et al.
Published: (2021-03-01) -
Induction of neutralizing antibodies against four serotypes of dengue viruses by MixBiEDIII, a tetravalent dengue vaccine.
by: Hui Zhao, et al.
Published: (2014-01-01) -
Dengue reporter virus particles for measuring neutralizing antibodies against each of the four dengue serotypes.
by: Kimberly Mattia, et al.
Published: (2011-01-01) -
A tetravalent live attenuated dengue virus vaccine stimulates balanced immunity to multiple serotypes in humans
by: Usha K. Nivarthi, et al.
Published: (2021-02-01)